Top entities: Stephanie Faubion, United States, Mayo Clinic Proceedings, Canadian Menopause Society.

What category does this event fall under?

Tech — classified as medical study.

What is the sentiment of coverage?

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Jun 04, 2026. Coverage continues to evolve.

Tech medical study

Mayo Clinic Study: US Hormone Therapy Use Low

Q: When did this event occur?

First reported Jun 01, 2026; last updated Jun 04, 2026.

Q: What is the market impact?

General. The study's findings could influence pharmaceutical companies producing hormone therapies, potentially leading to increased demand if educational efforts succeed in dispelling misconceptions.

Analysis based on 6 articles · First reported Jun 01, 2026 · Last updated Jun 04, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The study's findings could influence pharmaceutical companies producing hormone therapies, potentially leading to increased demand if educational efforts succeed in dispelling misconceptions. Healthcare providers and institutions like Mayo Clinic may see increased focus on menopause education and treatment protocols.

Healthcare Pharmaceuticals

Event Summary

A new study by Mayo Clinic, published in Mayo Clinic Proceedings>>>, reveals that hormone therapy use among women in the United States>>> remains low, despite its effectiveness in treating menopause symptoms. The study, co-authored by Stephanie Faubion>>>, found that use declined from 4.4% in 2007 to 1.7% in 2023. This trend is attributed to ongoing misconceptions about risks, limited clinician training, and patient concerns, stemming partly from past concerns raised by the Women s Health Initiative trial. Researchers emphasize the need for improved education for both patients and clinicians to address this gap in care.

Key Actions

80 Stephanie Faubion commented on findings

Entities Involved

per

Stephanie Faubion

Stephanie Faubion>>> is the director of Mayo Clinic's Center for Women's Health and a lead author of the study, providing expert commentary and driving the research findings.

Importance 80 Sentiment 10

cnt

United States

The study focuses on hormone therapy use trends among women in the United States>>>, indicating a national health concern and potential for policy or educational interventions.

Importance 60 Sentiment 0

oth

Mayo Clinic Proceedings

Mayo Clinic Proceedings>>> is the journal where the study was published, serving as the platform for disseminating the research findings.

Importance 40 Sentiment 0

ngo

Canadian Menopause Society

Canadian Menopause Society>>> is mentioned as a source for more information on hormone therapy, indicating its role in providing resources and education.

Importance 20 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard